These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9321736)

  • 21. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tachycardia in hypertension: a saga of progress despite prejudice, confusion, and inertia.
    Julius S
    Prog Cardiovasc Dis; 2009; 52(1):26-30. PubMed ID: 19615490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome.
    Brinkworth GD; Noakes M; Buckley JD; Clifton PM
    Am Heart J; 2006 Oct; 152(4):693.e1-6. PubMed ID: 16996838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemodynamic consequences of endogenous hyperinsulinism in obese rats with lesions of the ventromedial hypothalamus].
    Doaré L; Mesangeau D; Adli H; Germack R; Perret G; Valensi P
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1015-8. PubMed ID: 10989748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperinsulinemia instead of insulin resistance induces baroreflex dysfunction in chronic insulin-infused rats.
    Hong LZ; Hsieh PS
    Am J Hypertens; 2007 Apr; 20(4):451-8. PubMed ID: 17386355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated sympathetic activity may promote insulin resistance syndrome by activating alpha-1 adrenergic receptors on adipocytes.
    McCarty MF
    Med Hypotheses; 2004; 62(5):830-8. PubMed ID: 15082116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
    Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
    Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac sympathetic nerve stimulation triggers coronary t-PA release.
    Björkman JA; Jern S; Jern C
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1091-7. PubMed ID: 12714432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autonomic nervous system abnormalities in the initial phase of insulin resistance syndrome. Value of the study of variability of cardiac rate and blood pressure on a model of nutritional obesity].
    Verwaerde P; Galinier M; Fourcade J; Massabuau P; Galitzky J; Senard JM; Tran MA; Berlan M; Montastruc JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1151-4. PubMed ID: 9404426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats.
    El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM
    Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity.
    Palatini P; Longo D; Zaetta V; Perkovic D; Garbelotto R; Pessina AC
    J Hypertens; 2006 Jul; 24(7):1375-81. PubMed ID: 16794487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
    Egan BM; Papademetriou V; Wofford M; Calhoun D; Fernandes J; Riehle JE; Nesbitt S; Michelson E; Julius S;
    Am J Hypertens; 2005 Jan; 18(1):3-12. PubMed ID: 15691610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension.
    Tjugen TB; Flaa A; Kjeldsen SE
    Prog Cardiovasc Dis; 2009; 52(1):20-5. PubMed ID: 19615489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated heart rate: a major risk factor for cardiovascular disease.
    Palatini P; Julius S
    Clin Exp Hypertens; 2004; 26(7-8):637-44. PubMed ID: 15702618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The defense reaction: a common denominator of coronary risk and blood pressure in neurogenic hypertension?
    Julius S
    Clin Exp Hypertens; 1995; 17(1-2):375-86. PubMed ID: 7735282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of the adrenergic beta-receptors in emotional tachycardia; radiotelemetric studies on ski jumpers].
    Blatter K; Imhof P
    Schweiz Z Sportmed; 1969; 17(4):131-49. PubMed ID: 4395645
    [No Abstract]   [Full Text] [Related]  

  • 40. Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease.
    Palatini P
    Curr Hypertens Rep; 2001 Sep; 3 Suppl 1():S3-9. PubMed ID: 11580882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.